A nurse is assisting with the care of a client who has pneumonia.

For each potential nursing action, click to specify if the potential action is anticipated or contraindicated for the client.

A) Temporary memory loss: Temporary memory loss is a well-known and common side effect following electroconvulsive therapy (ECT). Clients may experience short-term memory issues, such as forgetting events that occurred around the time of the procedure or difficulties recalling information. This side effect is usually temporary and tends to resolve as the brain recovers from the procedure.

B) Voice alteration: Voice alteration is not a typical side effect of electroconvulsive therapy. ECT primarily affects brain function, particularly memory and cognitive processes, and does not have a direct effect on the voice or vocal cords.

C) Tingling of the scalp: Tingling of the scalp is not a common adverse reaction to
electroconvulsive therapy. While there may be some minor physical sensations or discomfort during the procedure, tingling is not a typical side effect associated with ECT.

D) Neck pain: Neck pain is not a usual adverse reaction of electroconvulsive therapy. Some discomfort might occur after the procedure due to muscle tension or the positioning during the therapy, but it is not a common or prominent side effect like memory loss.

A) Cimetidine: Cimetidine is an H2 receptor antagonist used to treat gastrointestinal issues like heartburn or ulcers. It does not have a known significant interaction with enoxaparin. Therefore, it is generally considered safe to use with enoxaparin, but it may require monitoring for other potential drug interactions, such as those with warfarin, not enoxaparin specifically.

B) Docusate: Docusate is a stool softener commonly used to prevent constipation. It does not interact with enoxaparin and is safe for use with the medication. It helps relieve constipation without increasing bleeding risks, which is a concern with certain other medications.

C) Calcium supplement: Calcium supplements are generally safe to use with enoxaparin. There is no significant interaction between calcium and enoxaparin, and calcium is often recommended for clients to maintain bone health, especially in those who are at risk of osteoporosis. Therefore, calcium supplements do not pose a risk when taken with enoxaparin.

D) Naproxen: Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) that increases the risk of bleeding. NSAIDs, including naproxen, inhibit platelet aggregation, which can potentiate the anticoagulant effects of enoxaparin and increase the risk of bleeding. Therefore, naproxen should be avoided in clients taking enoxaparin.